InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

AGENUS INC

AGEN Clue Score26
United States Fiscal year ends December CIK 0001098972
$7.67 +1.72% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.67 +35.75% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue22.6Operating income−107.5Net income−127.0Fiscal year 2017Revenue42.9 +89.9%Operating income−103.8Net income−120.7Fiscal year 2018Revenue36.8 −14.2%Operating income−123.8Net income−162.0Fiscal year 2019Revenue150.0 +307.9%Operating income−70.1Net income−111.6Fiscal year 2020Revenue88.2 −41.2%Operating income−117.2Net income−182.9EPS, diluted−1.05Fiscal year 2021Revenue295.7 +235.3%Operating income25.7Net income−28.7EPS, diluted−0.11Fiscal year 2022Revenue98.0 −66.8%Operating income−179.4Net income−230.7EPS, diluted−15.64Fiscal year 2023Revenue156.3 +59.5%Operating income−159.5EPS, diluted−13.75Fiscal year 2024Revenue103.5 −33.8%Operating income−120.5EPS, diluted−10.59Fiscal year 2025Revenue114.2 +10.4%Operating income−20.2EPS, diluted0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 22.6 42.9 36.8 150.0 88.2 295.7 98.0 156.3 103.5 114.2
Growth +89.9% −14.2% +307.9% −41.2% +235.3% −66.8% +59.5% −33.8% +10.4%
Operating income −107.5 −103.8 −123.8 −70.1 −117.2 25.7 −179.4 −159.5 −120.5 −20.2
Net income −127.0 −120.7 −162.0 −111.6 −182.9 −28.7 −230.7 n/a n/a n/a
Growth
EPS, diluted n/a n/a n/a n/a −1.05 −0.11 −15.64 −13.75 −10.59 0.00

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−476.1%Net margin−562.6%Free cash flow margin−409.7%Fiscal year 2017Operating margin−242.1%Net margin−281.5%Free cash flow margin−227.0%Fiscal year 2018Operating margin−336.6%Net margin−440.5%Free cash flow margin−366.2%Fiscal year 2019Operating margin−46.7%Net margin−74.3%Free cash flow margin−15.6%Fiscal year 2020Operating margin−133.0%Net margin−207.4%Free cash flow margin−161.7%Fiscal year 2021Operating margin8.7%Net margin−9.7%Free cash flow margin−8.0%Fiscal year 2022Operating margin−183.0%Net margin−235.3%Free cash flow margin−233.0%Fiscal year 2023Operating margin−102.1%Free cash flow margin−149.8%Fiscal year 2024Operating margin−116.4%Free cash flow margin−153.6%Fiscal year 2025Operating margin−17.7%Free cash flow margin−67.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −476.1% −242.1% −336.6% −46.7% −133.0% 8.7% −183.0% −102.1% −116.4% −17.7%
Net margin −562.6% −281.5% −440.5% −74.3% −207.4% −9.7% −235.3% n/a n/a n/a
Free cash flow margin −409.7% −227.0% −366.2% −15.6% −161.7% −8.0% −233.0% −149.8% −153.6% −67.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−80.0Capital expenditure−12.5Free cash flow−92.5Fiscal year 2017Operating cash flow−94.2Capital expenditure−3.1Free cash flow−97.3Fiscal year 2018Operating cash flow−131.1Capital expenditure−3.6Free cash flow−134.7Fiscal year 2019Operating cash flow−18.7Capital expenditure−4.7Free cash flow−23.3Fiscal year 2020Operating cash flow−139.1Capital expenditure−3.5Free cash flow−142.6Fiscal year 2021Operating cash flow10.1Capital expenditure−33.8Free cash flow−23.7Fiscal year 2022Operating cash flow−175.4Capital expenditure−53.1Free cash flow−228.4Fiscal year 2023Operating cash flow−224.2Capital expenditure−10.0Free cash flow−234.2Fiscal year 2024Operating cash flow−158.3Capital expenditure−0.6Free cash flow−158.9Fiscal year 2025Operating cash flow−77.2Capital expenditure−0.0Free cash flow−77.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −80.0 −94.2 −131.1 −18.7 −139.1 10.1 −175.4 −224.2 −158.3 −77.2
Capital expenditure −12.5 −3.1 −3.6 −4.7 −3.5 −33.8 −53.1 −10.0 −0.6 −0.0
Free cash flow −92.5 −97.3 −134.7 −23.3 −142.6 −23.7 −228.4 −234.2 −158.9 −77.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash71.4Total debt130.7Net cash (debt)−59.2Shareholders’ equity−39.1Fiscal year 2017Cash60.2Total debt163.0Net cash (debt)−102.8Shareholders’ equity−75.8Fiscal year 2018Cash53.1Total debt13.4Net cash (debt)39.7Shareholders’ equity−172.5Fiscal year 2019Cash61.8Total debt14.0Net cash (debt)47.8Shareholders’ equity−225.4Fiscal year 2020Cash99.9Total debt19.7Net cash (debt)80.2Shareholders’ equity−203.7Fiscal year 2021Cash291.9Total debt13.6Net cash (debt)278.4Shareholders’ equity34.4Debt to equity0.39Fiscal year 2022Cash178.7Total debt13.2Net cash (debt)165.5Shareholders’ equity−61.3Fiscal year 2023Cash76.1Total debt12.9Net cash (debt)63.2Shareholders’ equity−160.3Fiscal year 2024Cash40.4Total debt33.2Net cash (debt)7.3Shareholders’ equity−326.4Fiscal year 2025Cash3.0Total debt44.7Net cash (debt)−41.7Shareholders’ equity−271.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 71.4 60.2 53.1 61.8 99.9 291.9 178.7 76.1 40.4 3.0
Total debt 130.7 163.0 13.4 14.0 19.7 13.6 13.2 12.9 33.2 44.7
Net cash (debt) −59.2 −102.8 39.7 47.8 80.2 278.4 165.5 63.2 7.3 −41.7
Shareholders’ equity −39.1 −75.8 −172.5 −225.4 −203.7 34.4 −61.3 −160.3 −326.4 −271.1
Debt to equity n/a n/a n/a n/a n/a 0.39 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
22.6 42.9 36.8 150.0 88.2 295.7 98.0 156.3 103.5 114.2
Growth +89.9% −14.2% +307.9% −41.2% +235.3% −66.8% +59.5% −33.8% +10.4%
n/a n/a n/a n/a 2.3 3.5 10.6 3.1 0.5 1.0
95.0 116.1 124.6 168.3 142.6 178.6 186.7 234.6 155.5 79.3
33.1 33.7 37.3 46.0 59.2 76.4 81.0 78.7 71.9 54.4
−107.5 −103.8 −123.8 −70.1 −117.2 25.7 −179.4 −159.5 −120.5 −20.2
Growth −796.9%
−127.0 −120.7 n/a n/a n/a n/a n/a −257.4 −232.3 −3.1
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−127.0 −120.7 −162.0 −111.6 −182.9 −28.7 −230.7 n/a n/a n/a
Growth
Per share
n/a n/a n/a n/a −1.05 −0.11 −15.64 −13.75 −10.59 0.00
n/a n/a n/a n/a −1.05 −0.11 −15.64 −13.75 −10.59 0.00
Growth
n/a n/a n/a n/a 0.2 0.2 14.1 17.9 21.5 29.7
n/a n/a n/a n/a 0.2 0.2 14.1 17.9 21.5 29.7
Growth +32.7% +6,053.7% +27.0% +20.0% +38.5%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 5.3% a year over five years.
  • Operating margin is up 115.3 points on five years ago, at -17.7%.
  • A net loss in 7 of 7 years on file.